Intelligent Bio Solutions (NASDAQ:INBS) Posts Quarterly Earnings Results

Intelligent Bio Solutions (NASDAQ:INBS) announced its quarterly earnings results on Thursday. The company reported ($0.50) earnings per share for the quarter, Zacks reports. Intelligent Bio Solutions had a negative net margin of 288.35% and a negative return on equity of 147.50%. The company had revenue of $610 billion during the quarter.

Intelligent Bio Solutions Stock Up 7.6 %

Shares of INBS stock traded up $0.18 during midday trading on Friday, reaching $2.55. 447,850 shares of the stock were exchanged, compared to its average volume of 166,171. Intelligent Bio Solutions has a 1 year low of $1.00 and a 1 year high of $5.63. The company’s 50 day moving average is $1.56 and its two-hundred day moving average is $1.54.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.